In diabetic cardiomyocytes, mitochondrial Ago2 levels are significantly reduced.[53,62] Nevertheless, in type 1 diabetes, the increased miR-378 that inhibits ATP6 synthesis, in conjunction with Ago2, mediates the translational blockade of ATP6, diminishing the catalytic efficacy of ATP synthase. Here, AGO2 is linked to type 1 diabetes mellitus.